Is OpenID a panacea, a placebo, or something in between? Opposing viewpoints took turns on center stage Wednesday afternoon at OSCON 2008. The session entitled "A Critical View of OpenID" started off as anything but critical, but once the audience got its turn to raise questions, things got more interesting.
Full story »
